M16-438
ClinicalTrials.gov NCT03234712
Research payments
$1,375,045
Through program year 2020, $1,375,045 in research payments was reported against M16-438, across 164 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT03234712
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $521,235 | 78 |
| 2019 | Research | $853,810 | 86 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Kyriakos Papadopoulos San Antonio, TX Named on 45 payments
- Ani Balmanoukian Baltimore, MD Named on 37 payments
- Benedito Carneiro Filho Providence, RI Named on 18 payments
- Andrew Lassman New York, NY Named on 17 payments
- Christine Bestvina Chicago, IL Named on 15 payments
- John Strickler Durham, NC Named on 14 payments
- Young Kwang Chae Chicago, IL Named on 5 payments
- Ryan Merrell Evanston, IL Named on 3 payments
- Joseph Beck Fayetteville, AR Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.